title: [Low-dose radiation, therapy for choroidal neovascularization in age-related macular degeneration].
abstract: The efficacy of low-dose radiation was evaluated in the treatment of eyes with subfoveal or juxtafoveal choroidal neovascularization in age-related macular degeneration. Ten eyes of ten patients received a total dose of 14 Gy of 10 MV X-rays in seven fractions and the mean follow-up time was 12 months (range 9 approximately 18 months). Thirteen control eyes of thirteen patients were followed for an average of 18 months (range 12 approximately 24 months). Visual acuity was improved in 2 eyes (20%), unchanged in 3 eyes (30%), and deteriorated in 5 eyes (50%) of treated patients, and it was improved in no eyes (0%), unchanged in 5 eyes (32%), and deteriorated in 8 eyes (50%) of the control patients at their last follow-up examinations. Funduscopic and angiographic findings were improved in 3 eyes (30%), unchanged in 2 eyes (20%), and deteriorated in 5 eyes (50%) of treated patients, and they were improved in no eyes (0%), unchanged in 5 eyes (32%), and deteriorated in 8 eyes (50%) of the control patients. These results suggested that low-dose radiation is beneficial for the management of subfoveal or juxtafoveal choroidal neovascularization in age-related macular degeneration.
authors.affiliation: Department of Ophthalmology, Hirosaki University School of Medicine, Aomori-ken, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Matsuhashi
authors.forename: D
authors.initials: D
authors.lastname: Takahashi
authors.forename: Y
authors.initials: Y
authors.lastname: Noda
authors.forename: Y
authors.initials: Y
authors.lastname: Mariya
authors.forename: N
authors.initials: N
authors.lastname: Tarusawa
authors.forename: H
authors.initials: H
authors.lastname: Yoshimoto
authors.forename: S
authors.initials: S
authors.lastname: Matsuyama
mesh_terms: D000368:Aged; D002829:Choroid / Q000098:blood supply*; D005260:Female; D006801:Humans; D008268:Macular Degeneration / Q000150:complications*; D008297:Male; D008875:Middle Aged; D009389:Neovascularization, Pathologic / Q000209:etiology / Q000532:radiotherapy*; D011879:Radiotherapy Dosage